Literature DB >> 10999804

Abnormal cytokine and adrenocortical hormone regulation in myotonic dystrophy.

A Johansson1, K Carlström, B Ahrén, K Cederquist, E Krylborg, H Forsberg, T Olsson.   

Abstract

Metabolic-endocrine dysfunctions, including hyperinsulinemia, hypertriglyceridemia, increased fat mass, and dysregulation of the hypothalamic-pituitary-adrenal axis, are common in myotonic dystrophy (MD). We hypothesized that increased production of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) may be important underlying mechanisms. We studied the diurnal rhythmicity of cytokines and cortisol, ACTH, and dehydroepiandrosterone in 18 men with adult onset MD and 18 controls. Morning levels of androstenedione, 17-hydroxyprogesterone, testosterone, and insulin were also determined. Genetic analyses were performed, including calculation of allele sizes. Median circulating 24-h levels of IL-6 (P < 0.001), TNF-alpha (P = 0.05), ACTH (P < 0.05), and cortisol (P < 0.05) were all significantly increased in MD, whereas dehydroepiandrosterone levels were decreased (P < 0.001). The diurnal rhythms of these cytokines/ hormones were disturbed in patients. Morning testosterone levels were decreased and insulin levels increased (P < 0.01 for both). Patients with high body fat mass had significantly increased insulin levels and decreased morning levels of cortisol, ACTH, and testosterone. IL-6 and TNF-alpha levels are increased and adrenocortical hormone regulation is disturbed in MD. Adiposity may contribute to these disturbances, which may be of importance for decreased adrenal androgen hormone production and metabolic, muscular, and neuropsychiatric dysfunction in MD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999804     DOI: 10.1210/jcem.85.9.6794

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Daytime sleepiness and myotonic dystrophy.

Authors:  Luc Laberge; Cynthia Gagnon; Yves Dauvilliers
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

2.  Association of serum dehydroepiandrosterone sulfate and cognition in older adults: sex steroid, inflammatory, and metabolic mechanisms.

Authors:  Kerry L Hildreth; Wendolyn S Gozansky; Catherine M Jankowski; Jim Grigsby; Pamela Wolfe; Wendy M Kohrt
Journal:  Neuropsychology       Date:  2013-05       Impact factor: 3.295

3.  Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case-control study.

Authors:  M Spaziani; A Semeraro; E Bucci; F Rossi; M Garibaldi; M A Papassifachis; C Pozza; A Anzuini; A Lenzi; G Antonini; A F Radicioni
Journal:  J Endocrinol Invest       Date:  2019-11-30       Impact factor: 4.256

Review 4.  Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.

Authors:  Genevieve Ho; Michael Cardamone; Michelle Farrar
Journal:  World J Clin Pediatr       Date:  2015-11-08

5.  The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy.

Authors:  Libin Zhang; Jerome E Lee; Jeffrey Wilusz; Carol J Wilusz
Journal:  J Biol Chem       Date:  2008-06-16       Impact factor: 5.157

Review 6.  Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.

Authors:  Andrea Romigi; Valentina Franco; Fabio Placidi; Claudio Liguori; Emanuele Rastelli; Giuseppe Vitrani; Diego Centonze; Roberto Massa
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-31       Impact factor: 5.081

Review 7.  The role of the immune system in triplet repeat expansion diseases.

Authors:  Marta Olejniczak; Martyna O Urbanek; Wlodzimierz J Krzyzosiak
Journal:  Mediators Inflamm       Date:  2015-03-22       Impact factor: 4.711

Review 8.  Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic Dystrophies.

Authors:  A Romigi; M Albanese; C Liguori; F Placidi; M G Marciani; R Massa
Journal:  J Neurodegener Dis       Date:  2013-11-04

9.  Diurnal Variation of Circulating Interleukin-6 in Humans: A Meta-Analysis.

Authors:  Gustav Nilsonne; Mats Lekander; Torbjörn Åkerstedt; John Axelsson; Michael Ingre
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

10.  Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness.

Authors:  Yuki Omori; Takashi Kanbayashi; Aya Imanishi; Ko Tsutsui; Yohei Sagawa; Yuka S Kikuchi; Masahiro Takeshima; Kazuhisa Yoshizawa; Sachiko Uemura; Tetsuo Shimizu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-02-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.